Table 2

Summary table of case–control studies of the association between ILI and AMI

StudyStudy locationStudy design and study periodParticipant age
Mean (range)*
Prior AMI in study participantsILI in cases
n/N (%)
ILI in controls
n/N (%)
OR (95% CI)Adjusted confoundersVaccine coverageaOR (95% CI)Risk of bias score
Mattila30Helsinki, FinlandProspective hospital-based study; influenza season(s) unknownCases: 44.5 (34–50)
Controls without CHD: 41 (28–50)
Controls with CHD: 39.1 (30–50)
Cases: exclusion criteria not reported
Controls: 30/71 chronic CHD admitted for angiography
11/40 (28)8/71 (11.3)2.99 (1.09 to 8.21)†No adjustmentNot reportedNot calculatedHigh
Ponka et al26Helsinki, FinlandProspective hospital-based study; 1980 influenza seasonCases: 63 (36–82)
Controls: 68 (33–89)
Exclusion criteria not reported6/49 (12.2)4/37 (10.8)1.15 (0.30 to 4.41)†Date of hospital admissionNot reportedNot calculatedHigh
Warren-Gash et al28London, EnglandProspective hospital-based study; 2009–2010 influenza seasonAged ≥40 years
63.6 (IQR 53.3–72.6
Cases: prior AMI eligible (14/70)
Controls: 1-month history of AMI excluded (5/64 prior AMI)
10/71 (14.3)3/64 (4.7)3.39 (0.89 to 12.92)Influenza vaccination, personal and family history of myocardial infarction42.9% cases
45.3% controls
3.17 (0.61 to 16.47)Low
  • *Unless otherwise reported.

  • †Calculated from included data (not reported in original paper).

  • AMI, acute myocardial infarction; CHD, coronary heart disease; ILI, influenza-like illness.